Valuations remain the biggest constraint for Indian equities heading into 2026, limiting the margin of safety even as weak earnings growth and global uncertainty...
Lupin Ltd. on Wednesday, December 17, said the European Medicines Agency’s (EMA's) drug advisory committee has adopted a positive opinion and recommended marketing authorisation...